Patient Guide: A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 75 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07112339
Status: 🟢 Enrolling Now
Condition: Diabetes Mellitus, Type 2
Phase: PHASE4

Where You Can Participate

This study is available at 75 locations across the country.

Top locations include:
  • • Calgary, Alberta
  • • Edmonton, Alberta
  • • New Westminster, British Columbia
  • • And 72 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes - Join Clinical Trial NCTNCT07112339

How to Join This Clinical Trial - NCTNCT07112339

Learn how to participate in this PHASE4 trial studying an investigational therapy for Diabetes Mellitus, Type 2. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diabetes Mellitus, Type 2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diabetes Mellitus, Type 2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07112339 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 75 locations. Find a study site near you:

Clinical Research Site

Calgary, Alberta T2H 2G4 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

Edmonton, Alberta T5A 4L8 - Canada

Status: NOT_YET_RECRUITING

Clinical Research Site

New Westminster, British Columbia V3L 3W4 - Canada

Status: RECRUITING

Clinical Research Site

Winnipeg, Manitoba R3C 0N2 - Canada

Status: RECRUITING

Clinical Research Site

Moncton, New Brunswick E1G 1A7 - Canada

Status: RECRUITING

Clinical Research Site

Brampton, Ontario L6S 0C6 - Canada

Status: RECRUITING

Clinical Research Site

Burlington, Ontario L7M 4Y1 - Canada

Status: RECRUITING

Clinical Research Site

Concord, Ontario L4K 4M2 - Canada

Status: RECRUITING

Clinical Research Site

Courtice, Ontario L1E2J5 - Canada

Status: WITHDRAWN

Clinical Research Site

Etobicoke, Ontario M9R 4E1 - Canada

Status: RECRUITING

And 65 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Diabetes Mellitus, Type 2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships